Survival after DLT for recurrent CML based on type of relapse. Data as reported by the EBMT-1995 survey. Upper line (++) indicates molecular and cytogenetic relapse (n = 62); middle line (▵), hematologic relapse (n = 133); and lower line (○), relapse in transformed phase/blastic phase (n = 42).